Abstract
Noroviruses and norovirus virus-like particles (VLPs) exhibit strain specific patterns in their binding to ABH and Lewis histo-blood group antigens. In this study we demonstrate for the first time specific binding of Norwalk virus VLPs to type 1 and type 2 chain glycosphingolipids (GSLs) carrying ABH and Lewis antigens. N-succinimidyl-3-tributylstannyl benzoate (ATE) was precursor labeled with 125I and then conjugated to VLPs. The 125I-VLPs were used in GSL thin-layer chromatogram binding assays and displayed binding to H type 1, Lewis b, A type 1, A Lewis b GSLs but no binding to B type 1 or B Lewis b GSLs. For the type 2 chain GSLs the Norwalk VLPs bound to H type 2, Lewis y, A type 2 and A Lewis y. In addition, the VLPs bound to several complex GSLs from blood group O and A, but not from blood group B red blood cells.
Similar content being viewed by others
Abbreviations
- ATE:
-
N-succinimidyl-3-tributylstannyl benzoate
- BSA:
-
bovine serum albumin
- CBA:
-
chromatogram binding assay
- Cer:
-
ceramide
- cpm:
-
counts per minute
- DMSO:
-
dimethylsulfoxide
- ELISA:
-
enzyme-linked immunosorbent assay
- Fuc:
-
fucose
- FUT :
-
fucosyltransferase gene
- G:
-
genogroup
- Gal:
-
galactose
- GalNAc:
-
N-acetylgalactosamine
- Glc:
-
glucose
- GlcNAc:
-
N-acetylglucosamine
- GSL:
-
glycosphingolipid
- HPLC:
-
high performance liquid chromatography
- HRP:
-
horseradish peroxidase
- Le:
-
Lewis
- NV:
-
Norwalk virus
- NMR:
-
nuclear magnetic resonance
- PAA:
-
polyacrylamido
- PBS:
-
phosphate buffered saline
- RBC:
-
red blood cell
- TLC:
-
thin layer chromatography
- TMB:
-
3, 3’, 5, 5’-tetramethylbenzidine
- VLP:
-
virus-like particle
References
Hutson, A.M., Atmar, R.L., Estes, M.K.: Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 12, 279–287 (2004)
Tan, M., Jiang, X.: Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol. 13, 285–293 (2005)
Olofsson, S., Bergstrom, T.: Glycoconjugate glycans as viral receptors. Ann. Med. 37, 154–172 (2005)
Straub, T.M., HönerzuBentrup, K., Orosz-Coghlan, P., Dohnalkova, A., Mayer, B.K., Bartholomew, R.A., Valdez, C.O., Bruckner-Lea, C.J., Gerba, C.P., Abbaszadegan, M., Nickerson, C.A.: In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. Dis 13, 396–403 (2007)
Jiang, X., Wang, M., Graham, D.Y., Estes, M.K.: Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66, 6527–6532 (1992)
Green, K.Y., Lew, J.F., Jiang, X., Kapikian, A.Z., Estes, M.K.: Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31, 2185–2191 (1993)
Harrington, P.R., Vinje, J., Moe, C.L., Baric, R.S.: Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 78, 3035–3045 (2004)
Thorven, M., Grahn, A., Hedlund, K.O., Johansson, H., Wahlfrid, C., Larson, G., Svensson, L.: A homozygous nonsense mutation (428G–>t;A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79, 15351–15355 (2005)
Kapikian, A.Z.: The discovery of the 27-nm Norwalk virus: an historic perspective. J. Infect. Dis. 181(Suppl 2), S295–302 (2000)
Prasad, B.V., Hardy, M.E., Dokland, T., Bella, J., Rossmann, M.G., Estes, M.K.: X-ray crystallographic structure of the Norwalk virus capsid. Science 286, 287–290 (1999)
Bu, W., Mamedova, A., Tan, M., Xia, M., Jiang, X., Hegde, R.S.: Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 82, 5340–5347 (2008)
Choi, J.M., Hutson, A.M., Estes, M.K., Prasad, B.V.: Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA 105, 9175–9180 (2008)
Ravn, V., Dabelsteen, E.: Tissue distribution of histo-blood group antigens. Acta Pathol. Microbiol. Scand. 108, 1–28 (2000)
Le Pendu, J., Ruvoen-Clouet, N., Kindberg, E., Svensson, L.: Mendelian resistance to human norovirus infections. Semin. Immunol. 18, 375–386 (2006)
Harrington, P.R., Lindesmith, L., Yount, B., Moe, C.L., Baric, R.S.: Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76, 12335–12343 (2002)
Huang, P., Farkas, T., Marionneau, S., Zhong, W., Ruvoen-Clouet, N., Morrow, A.L., Altaye, M., Pickering, L.K., Newburg, D.S., LePendu, J., Jiang, X.: Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 188, 19–31 (2003)
Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., Baric, R.: Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548–553 (2003)
Marionneau, S., Ruvoen, N., Le Moullac-Vaidye, B., Clement, M., Cailleau-Thomas, A., Ruiz-Palacois, G., Huang, P., Jiang, X., Le Pendu, J.: Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967–1977 (2002)
Marionneau, S., Airaud, F., Bovin, N.V., Le Pendu, J., Ruvoen-Clouet, N.: Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J. Infect. Dis. 192, 1071–1077 (2005)
Thomsson, K.A., Prakobphol, A., Leffler, H., Reddy, M.S., Levine, M.J., Fisher, S.J., Hansson, G.C.: The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology 12, 1–14 (2002)
Hutson, A.M., Atmar, R.L., Marcus, D.M., Estes, M.K.: Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J. Virol. 77, 405–415 (2003)
Huang, P., Farkas, T., Zhong, W., Tan, M., Thornton, S., Morrow, A.L., Jiang, X.: Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714–6722 (2005)
Henry, S., Jovall, P.A., Ghardashkhani, S., Elmgren, A., Martinsson, T., Larson, G., Samuelsson, B.: Structural and immunochemical identification of Le(a), Le(b), H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor. Glycoconj. J. 14, 209–223 (1997)
Holgersson, J., Stromberg, N., Breimer, M.E.: Glycolipids of human large-intestine-difference in glycolipid expression related to anatomical localization, epithelial non-epithelial tissue and the Abo, Le and Se phenotypes of the donors. Biochimie 70, 1565–1574 (1988)
Karlsson, K.A., Larson, G.: Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a--b+) secretor. J. Biol. Chem 256, 3512–3524 (1981)
Brown, K.E., Anderson, S.M., Young, N.S.: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114–117 (1993)
Brown, K.E., Hibbs, J.R., Gallinella, G., Anderson, S.M., Lehman, E.D., McCarthy, P., Young, N.S.: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330, 1192–1196 (1994)
Tsai, B., Gilbert, J.M., Stehle, T., Lencer, W., Benjamin, T.L., Rapoport, T.A.: Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22, 4346–4355 (2003)
Karlsson, K.A., Stromberg, N.: Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses. Methods Enzymol. 138, 220–232 (1987)
Garg, P.K., Garg, S., Zalutsky, M.R.: N-Succinimidyl 4-methyl-3-(tri-n-butylstannyl) benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodies. Nucl. Med. Biol. 20, 379–387 (1993)
Lindegren, S., Andersson, H., Back, T., Jacobsson, L., Karlsson, B., Skarnemark, G.: High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl) benzoate. Nucl. Med. Biol. 28, 33–39 (2001)
Karlsson, K.A.: Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol. 138, 212–220 (1987)
Angstrom, J., Falk, K.E., Karlsson, K.A., Larson, G.: Chemical fingerprinting of non-acid glycosphingolipids in meconium of a human individual of blood group B Le(a-b+) and secretor. Biochim. Biophys. Acta 712, 274–282 (1982)
McKibbin, J.M., Spencer, W.A., Smith, E.L., Mansson, J.E., Karlsson, K.A., Samuelsson, B.E., Li, Y.T., Li, S.C.: Lewis blood group fucolipids and their isomers from human and canine intestine. J. Biol. Chem. 257, 755–760 (1982)
Stahl, E.: Dünnschichtchromatographie, p 817. Springer, Berlin (1967)
Procter, J., Crawford, J., Bunce, M., Welsh, K.I.: A rapid molecular method (polymerase chain reaction with sequence-specific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants. Tissue Antigens 50, 475–483 (1997)
Grahn, A., Elmgren, A., Aberg, L., Svensson, L., Jansson, P.A., Lönnroth, P., Larson, G.: Determination of Lewis FUT3 gene mutations by PCR using sequence-specific primers enables efficient genotyping of clinical samples. Hum. Mutat. 18, 358–359 (2001)
Dabrowski, J., Hanfland, P., Egge, H.: Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy. Biochemistry 19, 5652–5658 (1980)
Clausen, H., Levery, S.B., McKibbin, J.M., Hakomori, S.: Blood group A determinants with mono- and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry 24, 3578–3586 (1985)
Clausen, H., Levery, S.B., Kannagi, R., Hakomori, S.: Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J. Biol. Chem. 261, 1380–1387 (1986)
Angstrom, J., Larsson, T., Hansson, G.C., Karlsson, K.A., Henry, S.: Default biosynthesis pathway for blood group-related glycolipids in human small intestine as defined by structural identification of linear and branched glycosylceramides in a group O Le(a-b-) nonsecretor. Glycobiology 14, 1–12 (2004)
Ausar, S.F., Foubert, T.R., Hudson, M.H., Vedvick, T.S., Middaugh, C.R.: Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J. Biol. Chem. 281, 19478–19488 (2006)
Hansson, G.C.: Structural aspects of blood group glycosphingolipids in the gastrointestinal tract. Adv. Exp. Med. Biol. 228, 465–494 (1988)
Rydell, G.E., Nilsson, J., Rodriguez, J., Ruvoën-Clouet, N., Svensson, L., Le Pendu, J., Larson, G.: Human noroviruses recognize Sialyl Lewis x neoglycoprotein. Glycobiology 19, 309–320 (2009)
Shirato, H., Ogawa, S., Ito, H., Sato, T., Kameyama, A., Narimatsu, H., Xiaofan, Z., Miyamura, T., Wakita, T., Ishii, K., Takeda, N.: Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 82, 10756–10767 (2008)
Clausen, H., Watanabe, K., Kannagi, R., Levery, S.B., Nudelman, E., Arao-Tomono, Y., Hakomori, S.: Blood group A glycolipid (Ax) with globo-series structure which is specific for blood group A1 erythrocytes: one of the chemical bases for A1 and A2 distinction. Biochem. Biophys. Res. Commun. 124, 523–529 (1984)
Svensson, L., Rydberg, L., De Mattos, L., Henry, S.: Blood group A 1and A 2revisited: an immunochemical analysis. Vox Sang. 96, 56–61 (2009)
Clausen, H., Levery, S.B., Nudelman, E., Baldwin, M., Hakomori, S.: Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes. Biochemistry 25, 7075–7085 (1986)
Hanfland, P., Kordowicz, M., Niermann, H., Egge, H., Dabrowski, U., Peter-Katalinic, J., Dabrowski, J.: Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes. Eur. J. Biochem. 145, 531–542 (1984)
Hutson, A.M., Airaud, F., LePendu, J., Estes, M.K., Atmar, R.L.: Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 77, 116–120 (2005)
Smith, A.E., Lilie, H., Helenius, A.: Ganglioside-dependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett. 555, 199–203 (2003)
Delorme, C., Brussow, H., Sidoti, J., Roche, N., Karlsson, K.A., Neeser, J.R., Teneberg, S.: Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 75, 2276–2287 (2001)
Fraker, P.J., Speck, J.C.: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α, 6α-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849–857 (1978)
Bolton, A.E., Hunter, W.M.: The labeling of proteins to high specific radioactivites by conjugation to a 125I-containing acylating agent. Biochem. J. 133, 529–539 (1973)
Tan, M., Jin, M., Xie, H., Duan, Z., Jiang, X., Fang, Z.: Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J. Med. Virol. 80, 1296–1301 (2008)
Kindberg, E., Akerlind, B., Johnsen, C., Knudsen, J.D., Heltberg, O., Larson, G., Bottiger, B., Svensson, L.: Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J. Clin. Microbiol. 45, 2720–2722 (2007)
Larsson, M.M., Rydell, G.E., Grahn, A., Rodriguez-Diaz, J., Akerlind, B., Hutson, A.M., Estes, M.K., Larson, G., Svensson, L.: Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J. Infect. Dis. 194, 1422–1427 (2006)
White, L.J., Ball, J.M., Hardy, M.E., Tanaka, T.N., Kitamoto, N., Estes, M.K.: Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J. Virol. 70, 6589–6597 (1996)
Mollicone, R., Cailleau, A., Oriol, R.: Molecular genetics of H, Se, Lewis and other fucosyltransferase genes. Transfus. Clin. Biol. 2, 235–242 (1995)
Acknowledgments
The authors would like to thank Dr. Sture Lindegren for initial help with the radioiodination protocol, Dr. N. Ruvoën-Clouet (Nantes, France) for help with the NV VLPs purification and antiserum preparation and Dr. Peter Påhlsson (Linköping, Sweden) for the anti-H type 1 monoclonal antibody. We acknowledge the Swedish NMR centre at Hasselblad laboratory, Göteborg University, for their kind supply of NMR spectrometers. The work was supported by grants from the Swedish Research Council (8266), by Governmental grants (ALF) to the Sahlgrenska University Hospital and the French Region Pays de la Loire (CIMATH).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nilsson, J., Rydell, G.E., Le Pendu, J. et al. Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj J 26, 1171–1180 (2009). https://doi.org/10.1007/s10719-009-9237-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-009-9237-x